Therapeutic targeting of childhood medulloblastoma

1 Views

07/06/23

Dr Singh speaks with ecancertv at NCRI 2016 about the pathways through which cancer stem cells drive tumourigenesis and subvert treatments, in the specific setting of medulloblastoma.

She describes research with patient-derived xenograft models to modify treatment regimens, giving insight into opportunities to avoid the systemic toxicities associated with current therapies.